Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

PharmaCyte Biotech (PMCBD) News Today

→ Boost your retirement with these AI payouts (From InvestorPlace) (Ad)
Free PMCBD Stock Alerts
$2.10
+0.01 (+0.48%)
(As of 05/17/2024 ET)
Compare
Stock AnalysisChart
March 19, 2024 | investorplace.com
PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024
February 22, 2024 | investing.com
PharmaCyte Biotech Inc (PMCB)
October 27, 2023 | ft.com
Exploring beauty’s biotech frontier
May 26, 2023 | seekingalpha.com
PMCB PharmaCyte Biotech, Inc.
May 11, 2023 | marketwatch.com
PharmaCyte Biotech Shares Up 13% to 52-Week High After Cash Tender Offer
April 28, 2023 | bizjournals.com
Baltimore Biotech News
March 30, 2023 | techcrunch.com
Biotech & Health
October 7, 2022 | finance.yahoo.com
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
September 28, 2022 | finanznachrichten.de
BLACK BIRD BIOTECH INC
July 28, 2022 | finance.yahoo.com
PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation
July 19, 2022 | apnews.com
PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study
July 5, 2022 | finance.yahoo.com
IROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT ACTIONS BY THE PHARMACYTE BIOTECH BOARD OF DIRECTORS
June 2, 2022 | seekingalpha.com
PharmaCyte Biotech announces $10M share buyback program
June 2, 2022 | seekingalpha.com
PharmaCyte Biotech stock rises on $10M stock buyback plan
June 2, 2022 | apnews.com
PharmaCyte Biotech to Implement $10-Million Share Repurchase Program
May 23, 2022 | stockhouse.com
PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites
February 10, 2022 | finance.yahoo.com
PharmaCyte Biotech, Inc. (PMCB)
January 6, 2022 | finance.yahoo.com
PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference
December 28, 2021 | businesswire.com
PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study
December 8, 2021 | stockhouse.com
PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay
November 30, 2021 | businesswire.com
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study
November 12, 2021 | finance.yahoo.com
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation
September 16, 2021 | feeds.benzinga.com
Why Are PharmaCyte Shares Moving Higher On Thursday?
August 12, 2021 | finance.yahoo.com
PharmaCyte Biotech Announces Closing of $15-Million Public Offering
Get PharmaCyte Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for PMCBD and its competitors with MarketBeat's FREE daily newsletter.

Digitizing the $11T commodities sector with one tiny stock (Ad)

One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector.

It’s an opportunity that likely won’t stay at these levels for long

PMCBD Media Mentions By Week

PMCBD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PMCBD
News Sentiment
▼
0.00

0.42
▲
Average
Medical
News Sentiment

PMCBD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PMCBD Articles
This Week
▼
0

0
▲
PMCBD Articles
Average Week

Get PharmaCyte Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for PMCBD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (OTCMKTS:PMCBD) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
Elon to Transform U.S. Economy?
Porter & Company
Former CIA advisor: Dark side of AI now starting
Paradigm Press